Quince Therapeutics Advances Trials on EryDex
by Denny Jacob Quince Therapeutics announced its plans to move forward with trials on EryDex after the U.S. Food and Drug Administration (FDA) lifted the hold on EryDel's investigational new…
Positive Results in Late-Stage Trial for Lung Cancer Treatment
Eli Lilly & Co. (LLY) has reported significant progress in a Phase 3 clinical trial of their treatment for a specific type of non-small cell lung cancer. The trial, called…
ZyVersa Therapeutics Receives European Patent for VAR 200
Shares of ZyVersa Therapeutics saw a 9.2% increase in trading today following the announcement that the company has been granted a patent for its kidney disease treatment, VAR 200, by…